These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 16116424)

  • 1. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
    Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.
    Levitus M; Waisfisz Q; Godthelp BC; de Vries Y; Hussain S; Wiegant WW; Elghalbzouri-Maghrani E; Steltenpool J; Rooimans MA; Pals G; Arwert F; Mathew CG; Zdzienicka MZ; Hiom K; De Winter JP; Joenje H
    Nat Genet; 2005 Sep; 37(9):934-5. PubMed ID: 16116423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FANCE: the link between Fanconi anaemia complex assembly and activity.
    Pace P; Johnson M; Tan WM; Mosedale G; Sng C; Hoatlin M; de Winter J; Joenje H; Gergely F; Patel KJ
    EMBO J; 2002 Jul; 21(13):3414-23. PubMed ID: 12093742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
    Taniguchi T; D'Andrea AD
    Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
    Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
    Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked inheritance of Fanconi anemia complementation group B.
    Meetei AR; Levitus M; Xue Y; Medhurst AL; Zwaan M; Ling C; Rooimans MA; Bier P; Hoatlin M; Pals G; de Winter JP; Wang W; Joenje H
    Nat Genet; 2004 Nov; 36(11):1219-24. PubMed ID: 15502827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.
    Gordon SM; Buchwald M
    Blood; 2003 Jul; 102(1):136-41. PubMed ID: 12649160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
    Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
    Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway.
    van Twest S; Murphy VJ; Hodson C; Tan W; Swuec P; O'Rourke JJ; Heierhorst J; Crismani W; Deans AJ
    Mol Cell; 2017 Jan; 65(2):247-259. PubMed ID: 27986371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
    Huber PA; Medhurst AL; Youssoufian H; Mathew CG
    Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of Fanconi anaemia--an old problem, a new insight.
    Ahmad SI; Hanaoka F; Kirk SH
    Bioessays; 2002 May; 24(5):439-48. PubMed ID: 12001267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of fanconi anemia.
    Taniguchi T; Dandrea AD
    Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular biology of Fanconi anemia.
    Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
    Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
    Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
    Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.